All sponsors

Sanofi $SNY

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS100
PHASE 3 / 2-356
RECRUITING42
READOUTS ≤12 MONTHS33
READOUT SLIPPED >6 MO37%

Delay Index: of 76 active trials registered more than a year ago, 28 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Sanofi on the live radar map → 📅 $SNY readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
SAR441344 IV
NCT04879628
P2Active, not recruitingMultiple Sclerosis1292022-09-21 (-3 mo)
LUMINA 2
NCT05002777
P2Active, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)222024-05-23 (+10 mo)
IRAKLIA
NCT05405166
P3Active, not recruitingPlasma Cell Myeloma Recurrent5312024-11-06 (+5 mo)
LEAP2MONO
NCT05222906
P3Active, not recruitingGaucher's Disease Type III432025-10-02 (+13 mo)
BIVV020 (SAR445088)
NCT05156710
P2Active, not recruitingTransplant Rejection482025-10-21 (+11 mo)
PERIDOT
NCT05206773
P3Active, not recruitingFabry Disease1222025-12-17 (+13 mo)
IZALCO
NCT05704049
P2Active, not recruitingRelapsed/Refractory Multiple Myeloma1182025-12-22 (+18 mo)
RESOLUTE
NCT05588843
P2Active, not recruitingColitis Ulcerative1872026-02-10 (+8 mo)
Baby-COMET
NCT04910776
P3Active, not recruitingGlycogen Storage Disease Type II172026-03-02 (+22 mo)
Dupilumab
NCT05731128
P2Active, not recruitingColitis Ulcerative682026-05-13 (+23 mo)
CARAT
NCT05280548
P3Active, not recruitingFabry Disease1042026-05-22 (+17 mo)
MOBILIZE
NCT06290128
P3Active, not recruitingChronic Inflammatory Demyelinating Polyradiculoneuropathy; Polyneuropathy, Inflammatory Demyelinating, Chronic1092026-06-10 (+4 mo)
ESTUARY
NCT06407934
P3Active, not recruitingDermatitis Atopic15412026-06-10
Amlitelimab
NCT06557772
P2Active, not recruitingCoeliac Disease; Celiac Disease2292026-08-05
APATURA
NCT05039840
P2Active, not recruitingSystemic Lupus Erythematosus1092026-09-04 (+39 mo)
CEREN-1
NCT06834347
P3Active, not recruitingChronic Rhinosinusitis With Nasal Polyps2312026-09-23 (-4 mo)
CEREN-2
NCT06834360
P3Active, not recruitingChronic Rhinosinusitis With Nasal Polyps2162026-09-24 (-3 mo)
rilzabrutinib
NCT07216079
P3Active, not recruitingImmune Thrombocytopenia32026-11-25
Yellow fever vaccine (live)
NCT07103148
P3Active, not recruitingYellow Fever Immunization24402026-11-28 (+4 mo)
Pandemic flu H5 HA mRNA SD2 vaccine
NCT06907511
P1/2Active, not recruitingPandemic Influenza Immunization; Healthy Volunteers7202026-12-01 (+6 mo)
CHROMA CD
NCT06958536
P2RecruitingCrohn's Disease992026-12-17
COLOR UC
NCT06975722
P2Active, not recruitingUlcerative Colitis1052026-12-17
RESULT
NCT06500702
P2RecruitingFocal Segmental Glomerulosclerosis; Glomerulonephritis Minimal Lesion842026-12-23
PCV21
NCT07247188
P3RecruitingSickle Cell Disease1002027-01-07
SAR445877
NCT05584670
P1/2RecruitingSolid Tumor5422027-01-19 (-5 mo)
BRIGHTEN
NCT07170917
P2RecruitingHidradenitis Suppurativa2082027-02-09 (-6 mo)
Rilzabrutinib dose 1
NCT06984627
P2RecruitingGraves' Disease302027-02-11 (+6 mo)
CEREN-3
NCT07424144
P3Active, not recruitingChronic Rhinosinusitis With Nasal Polyps592027-02-17
ATLAS-NEO
NCT05662319
P3Active, not recruitingHemophilia912027-03-25 (+11 mo)
SubQSA
NCT06356571
P2Active, not recruitingPlasma Cell Myeloma Refractory642027-04-01 (+3 mo)
IMROZ
NCT03319667
P3Active, not recruitingPlasma Cell Myeloma4752027-04-05 (+52 mo)
SAR444336
NCT07156175
P2Active, not recruitingMicroscopic Colitis602027-04-08
FABULINUS
NCT06111586
P2Active, not recruitingType 1 Diabetes Mellitus1972027-04-28
T1D OBTAIN
NCT06812988
P2Active, not recruitingType 1 Diabetes Mellitus842027-04-29 (-3 mo)
FREXALT
NCT06141473
P3Active, not recruitingMultiple Sclerosis16552027-05-06
SAR402663
NCT06660667
P1/2Active, not recruitingNeovascular Age-related Macular Degeneration662027-05-18
Dupilumab
NCT05263206
P3RecruitingPruritus2842027-06-02 (+26 mo)
PCV21 vaccine
NCT07348692
P3RecruitingPneumococcal Immunization; Healthy Volunteers21952027-06-07
AIRLYMPUS
NCT06676319
P2Active, not recruitingAsthma5562027-06-21 (-4 mo)
VITALIZE
NCT06290141
P3RecruitingChronic Inflammatory Demyelinating Polyneuropathy1602027-07-09 (+20 mo)
Frexcite
NCT07325292
P3RecruitingMultiple Sclerosis1602027-07-15
LIBRA
NCT06975865
P3RecruitingSickle Cell Disease1922027-07-23
PCV21 vaccine
NCT06975878
P3Active, not recruitingPneumococcal Immunization; Healthy Volunteers10922027-08-25
PCV21 vaccine
NCT06824181
P3Active, not recruitingPneumococcal Immunization5802027-09-10 (+4 mo)
Isatuximab
NCT04643002
P1/2RecruitingPlasma Cell Myeloma Refractory2582027-09-13 (+53 mo)
CLAROS
NCT07225569
P2RecruitingHidradenitis Suppurativa1442027-09-22
AQUA
NCT06241118
P3Active, not recruitingDermatitis Atopic4642027-09-30 (+18 mo)
SAR446597
NCT07215234
P1/2RecruitingGeographic Atrophy1042027-10-13
PCV21 vaccine
NCT06824194
P3Active, not recruitingPneumococcal Immunization23602027-10-22 (+5 mo)
Dupilumab
NCT06293053
P3RecruitingPrurigo Nodularis182027-10-28
LUNA 4
NCT07007962
P3RecruitingImmune Thrombocytopenia602027-11-05
IIV-HD (standalone)
NCT07890454
P3RecruitingImmunization; Healthy Volunteers60002027-12-28
Flu H5 egg pandemic low dose vaccine, with adjuvant
NCT07779408
P1/2RecruitingHealthy Volunteers; Influenza6402028-02-22
SKYPS
NCT02991469
P2RecruitingJuvenile Idiopathic Arthritis512028-03-01 (+119 mo)
KIBOU-T1D
NCT06791291
P2Active, not recruitingType 1 Diabetes Mellitus52028-03-06
MenQuadfi® (Meningococcal Polysaccharide [Serogroups A, C, W, and Y] Tetanus Toxoid Conjugate Vaccine) (Sanofi Pasteur Inc., Swiftwater, PA, USA)
NCT07710872
P3RecruitingMeningococcal Infection; Healthy Volunteers45682028-03-13
FREVIVA
NCT06141486
P3Active, not recruitingMultiple Sclerosis9432028-03-24 (+15 mo)
DTaP-IPV-HB-PRP~T combined vaccine
NCT07941622
P3Not yet recruitingHaemophilus Influenzae Type b Immunisation; Hepatitis B Immunisation7202028-04-27
EXTENSA
NCT07919899
P3Not yet recruitingDermatitis Atopic1502028-05-02
RSV+HMPV vaccine
NCT07734649
P1/2RecruitingRespiratory Syncytial Virus Immunization; Human Metapneumovirus Immunization24002028-05-03
SUNSCAPE-1
NCT07184996
P3RecruitingUlcerative Colitis9802028-05-09
LUMINA 3
NCT07086976
P3RecruitingAutoimmune Haemolytic Anaemia902028-05-31
βETA PRESERVE
NCT07088068
P3RecruitingType 1 Diabetes Mellitus7232028-06-06
AURALIGHT
NCT07812116
P2RecruitingHidradenitis1562028-06-16
RILIEF
NCT07190196
P3RecruitingImmunoglobulin G4 Related Disease1242028-06-28
ELEVAATE OLE
NCT05897424
P2Active, not recruitingAlpha 1-Antitrypsin Deficiency; Emphysema1852028-06-30 (+10 mo)
Bivalent RSV+HMPV protein vaccine
NCT07810010
P2RecruitingRespiratory Syncytial Virus; Human Metapneumovirus80002028-07-03
Acne mRNA (messenger ribonucleic acid) vaccine
NCT07756957
P2Not yet recruitingAcne4102028-07-19
SAR445877
NCT07692204
P2RecruitingGastric Cancer; Oesophageal Carcinoma302028-08-02
SUNSCAPE-2
NCT07185009
P3RecruitingUlcerative Colitis7512028-09-21
schoolROCK
NCT07116031
P2RecruitingChronic Graft Versus Host Disease372028-09-25 (-29 mo)
ROCKnrol-1
NCT06143891
P3Active, not recruitingChronic Graft Versus Host Disease2602028-09-29
OPALS
NCT07704580
P1/2RecruitingRheumatoid Arthritis1402028-10-26
Isatuximab intravenous (IV)
NCT05669989
P2Enrolling by invitationPlasma Cell Myeloma702028-11-30 (+29 mo)
Dupilumab
NCT06191315
P3Enrolling by invitationWheezing; Asthma902028-12-21
RIVER-AD
NCT05492578
P2/3Active, not recruitingDermatitis Atopic18562029-01-22 (+38 mo)
ROCKaspire
NCT06082037
P3RecruitingLung Transplant Rejection1802029-01-29 (+28 mo)
ENSEMBLE
NCT06914908
P2Active, not recruitingChronic Rhinosinusitis With Nasal Polyps712029-02-22 (-23 mo)
BrAAVe
NCT06844214
P1/2RecruitingMyotonic Dystrophy322029-02-28
Tolebrutinib
NCT06372145
P3Active, not recruitingRelapsing Multiple Sclerosis; Secondary Progressive Multiple Sclerosis25002029-04-30
STARSCAPE-1
NCT07184931
P3RecruitingCrohn's Disease9802029-05-14
ZIRCON
NCT07286214
P3RecruitingPolymyalgia Rheumatica3002029-06-04
TREMHANCE
NCT07688213
P2RecruitingDementia, Alzheimer's Type; Alzheimer's Disease1602029-07-31
ATLAS-KIDS
NCT07285460
P3RecruitingHemophilia852029-08-04
STARSCAPE-2
NCT07184944
P3RecruitingCrohn's Disease7512029-08-13
FREXERA
NCT07412470
P2/3RecruitingKidney Transplant Rejection5262029-08-15
Belumosudil
NCT07771439
P3RecruitingChronic Graft Versus Host Disease3562029-09-14
LTS
NCT06859099
P3Enrolling by invitationPolyneuropathy, Inflammatory Demyelinating, Chronic3002029-10-03
THESEUS
NCT07190222
P3RecruitingChronic Obstructive Pulmonary Disease9422029-11-27
PERSEPHONE
NCT07190209
P3RecruitingChronic Obstructive Pulmonary Disease9422029-11-27
LEAP2KIDS
NCT07927140
P3Not yet recruitingGaucher's Disease Type III182030-01-14
SAR444836
NCT05972629
P1/2Active, not recruitingPhenylketonuria322030-04-02 (+33 mo)
Isatuximab SAR650984
NCT04270409
P3Active, not recruitingPlasma Cell Myeloma3372030-10-14 (+34 mo)
AIRPHRODITE
NCT06609239
P2Enrolling by invitationAsthma9002031-01-20
Frexalimab
NCT07930624
P3Not yet recruitingMultiple Sclerosis25002031-05-16
ATLANTIS
NCT05769777
P2Active, not recruitingDermatitis Atopic9992031-06-11 (+43 mo)
Blood draw for the laboratory assessment
NCT02065011
P2Active, not recruitingUsher's Syndrome92031-06-13 (+13 mo)
COLOSSUS
NCT07793409
P3Enrolling by invitationChronic Obstructive Pulmonary Disease15082031-07-23
Long term follow up in all patients who received SAR422459 in previous study TDU13583
NCT01736592
P2Active, not recruitingStargardt's Disease272033-08-29 (+58 mo)
rilzabrutinib
NCT07923305
P2/3Not yet recruitingImmunodeficiency Common Variable962035-05-10